We are live on ! Find out more
VCM

Voleon Capital Management Portfolio holdings

AUM $5.49B
1-Year Est. Return 56.94%
This Fund
S&P 500
This Quarter Est. Return
+31.2%
1 Year Est. Return
+56.94%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.49B
AUM Growth
+$849M
Cap. Flow
+$57M
Cap. Flow %
1.04%
Top 10 Hldgs %
29.1%
Holding
957
New
177
Increased
251
Reduced
333
Closed
196

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$41.7M
2
META icon
Meta Platforms (Facebook)
META
+$41.2M
3
MRK icon
Merck
MRK
+$26.1M
4
INTU icon
Intuit
INTU
+$24.7M
5
AZN icon
AstraZeneca
AZN
+$23.6M

Top Sells

Rank Stock Value
1
ALAB icon
Astera Labs
ALAB
+$29.3M
2
QCOM icon
Qualcomm
QCOM
+$28.6M
3
FTNT icon
Fortinet
FTNT
+$26.2M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$22.1M
5
LLY icon
Eli Lilly
LLY
+$20.8M

Sector Composition

Rank Sector Weight
1 Technology 34.25%
2 Financials 12.04%
3 Healthcare 11.39%
4 Industrials 10.72%
5 Consumer Discretionary 10.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BN icon
126
Brookfield
BN
$85.3B
$9.42M 0.17%
221,231
+37,176
+20% +$1.66M
JBLU icon
127
JetBlue
JBLU
$1.66B
$9.42M 0.17%
1,643,594
+220,499
+15% +$1.12M
CRDO icon
128
Credo Technology Group
CRDO
$30.6B
$9.35M 0.17%
34,370
+27,069
+371% +$5.35M
CBC
129
Central Bancompany Inc
CBC
$7.76B
$9.24M 0.17%
+304,189
New +$8.27M
EXC icon
130
Exelon
EXC
$44.5B
$9.13M 0.17%
195,781
-22,816
-10% -$1.06M
PTON icon
131
Peloton Interactive
PTON
$2.17B
$8.94M 0.16%
1,512,312
+1,355,387
+864% +$7.31M
DK icon
132
Delek US
DK
$4.66B
$8.88M 0.16%
174,673
-153,547
-47% -$6.81M
ECG
133
Everus Construction Group
ECG
$6.1B
$8.82M 0.16%
53,161
+41,301
+348% +$6.05M
GFS icon
134
GlobalFoundries
GFS
$25.8B
$8.78M 0.16%
+106,494
New +$7.44M
RBRK icon
135
Rubrik
RBRK
$18B
$8.61M 0.16%
107,273
-223,686
-68% -$14.1M
BIP icon
136
Brookfield Infrastructure Partners
BIP
$17B
$8.61M 0.16%
235,860
-44,117
-16% -$1.65M
FRSH icon
137
Freshworks
FRSH
$3.1B
$8.48M 0.15%
837,996
+771,659
+1,163% +$6.87M
DDS icon
138
Dillards
DDS
$10.2B
$8.42M 0.15%
15,929
-4,821
-23% -$2.78M
AMRX icon
139
Amneal Pharmaceuticals
AMRX
$5.92B
$8.41M 0.15%
486,052
-300,712
-38% -$4.12M
PODD icon
140
Insulet
PODD
$9.15B
$8.38M 0.15%
+55,044
New +$9.17M
TVTX icon
141
Travere Therapeutics
TVTX
$6.24B
$8.27M 0.15%
145,655
+102,300
+236% +$4.54M
GRAL
142
GRAIL Inc
GRAL
$3.4B
$8.26M 0.15%
121,062
-23,893
-16% -$1.41M
CORT icon
143
Corcept Therapeutics
CORT
$12.2B
$7.99M 0.15%
91,926
-170,297
-65% -$10.3M
GWW icon
144
W.W. Grainger
GWW
$60.3B
$7.98M 0.15%
5,867
+3,682
+169% +$4.54M
PBF icon
145
PBF Energy
PBF
$9.28B
$7.98M 0.15%
175,288
-237,048
-57% -$9.86M
XIFR
146
XPLR Infrastructure LP
XIFR
$1.08B
$7.87M 0.14%
666,638
+123,021
+23% +$1.37M
LYV icon
147
Live Nation Entertainment
LYV
$39.6B
$7.79M 0.14%
+42,540
New +$7M
SCCO icon
148
Southern Copper
SCCO
$163B
$7.79M 0.14%
45,233
+7,913
+21% +$1.42M
CRCL
149
Circle Internet Group
CRCL
$23B
$7.65M 0.14%
122,173
+83,901
+219% +$8.17M
ITW icon
150
Illinois Tool Works
ITW
$76.4B
$7.65M 0.14%
28,283
+11,860
+72% +$3.08M
4 5
6
7 8

Similar funds

GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $5.5B AUM 26.66% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
NC
Nicholas Company Milwaukee, Wisconsin $5.47B AUM 16.96% 1-Year Est. Return
EI
EFG International Zurich $5.46B AUM
MC
Maplelane Capital New York $5.51B AUM 67.92% 1-Year Est. Return
AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return

Voleon Capital Management's Q2 2026 Portfolio in Review

As of Q2 2026, Voleon Capital Management held 957 positions worth $5.49B, up 18% from $4.64B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Voleon Capital Management's Q2 2026 filing shows 177 new, 251 increased, 333 reduced and 196 closed positions. Its largest new stake was AstraZeneca: 125,385 shares worth $23.8M. The largest sale was Astera Labs, an estimated $29.3M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.

  • Voleon Capital Management's largest Q2 2026 buy was AstraZeneca: 125,385 shares worth $23.8M.
  • Voleon Capital Management added most to Microsoft in Q2 2026, an estimated $41.7M increase.
  • Voleon Capital Management's biggest Q2 2026 reduction was Astera Labs, cutting an estimated $29.3M.
  • Voleon Capital Management fully exited Ascendis Pharma A/S in Q2 2026, selling an estimated $15.5M.
  • Voleon Capital Management's ten largest holdings make up 29% of its $5.49B portfolio in Q2 2026.
  • Voleon Capital Management opened 177 new positions and closed 196 in Q2 2026.
  • Voleon Capital Management's portfolio value rose 18% quarter-over-quarter to $5.49B.

Based on Voleon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.